BCDA → $32.70 by Oct 6, 2027.

I highly suggest you to do some dd in this company. Late stage bio company dealing with heart failure and chronic myocardial ischemia. Very realistic 30x upside potential in a year with ridiculous 15m market cap. Founded 1996 and CEO (been there developing the tech for 20 years) has started buying heavy. Near catalysts ahead, just filed Revised De Novo Pre-Submission for FDA Approval of their Helix catheter system. And that's not even their biggest catalyst coming in a year. …